activity Data Safety Monitoring Committee for Protocol ITL-2002-CL-001 entitled “Phase 1/2 Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2002 in Adults with Hereditary Angioedema (HAE)
Intellia Pharmaceuticals01/28/2023 - Presentactivity Virtual Medical Advisory Board
Biocryst Pharmaceuticals03/02/2021 - Presentactivity Systemic Mastocytosis Advisory Board
Blueprint Medicines07/17/2020 - Presentactivity HAE Virtual Advisory Board,
Takeda Pharmaceutical Company07/25/2020 - Presentactivity Advances in Hereditary Angioedema (HAE) Prophylaxis Advisory Board
Biocryst Pharmaceuticals06/22/2019 - Presentactivity Lanadelumab Virtual Advisory Board
Shire Pharmaceuticals04/24/2018 - Presentactivity HAE Scientific Advisory Board
CSL Behring04/08/2017 - Presentactivity JACI: In Practice
2016 - Presentactivity The Journal of Allergy and Clinical Immunology
2010 - Presentactivity American Academy of Allergy, Asthma, and Immunology (AAAAI)
Training Program Director Assembly2018 - Presentactivity American Academy of Allergy, Asthma, and Immunology (AAAAI)
Elected to Fellowship in March 20102010 - Presentactivity Yale School of Medicine
2016 - Presentactivity Program Evaluation Committee Allergy and Immunology Fellowship
2018 - Presentactivity Chinese Language School of Fairfield County
(Registration Chair 2019-2020, 2021-present)2019 - Presentactivity eConsult Specialist Advisory Group
2021 - Presentactivity “Approach to Aspirin/NSAID Drug Allergy”
activity COVID-19 Vaccine Medical Exemption Review Committee
2021 - 2022activity COVID-19 Vaccine Clinical Advisory Group
Yale-New Haven Hospital System2021 - 2022activity “Advances in the Clinical Management of Hereditary Angioedema”
activity “Recognition and Management of Aspirin Exacerbated Respiratory Disease (AERD)”